Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872116 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 7 Pages |
Abstract
Conclusions: It was concluded that HDR brachytherapy combined with hypofractionated EBRT is feasible for localized prostate cancer, when considered from the viewpoint of acute toxicity. However, because the urethral dose was closely associated with the grade of severity of the acute GU toxicity, the urethral dose in HDR brachytherapy must be kept low to reduce the severity of acute GU toxicity.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Tetsuo M.D., Ph.D., Hiroyuki M.D., Shin-ei M.D., Kazuto M.D., Ph.D., Takumi M.D., Bunzo M.D., Takashi M.D., Ph.D.,